Zheng Quan Shi Bao Wang·2025-07-07 10:31Group 1 - The weight loss drug concept sector experienced a decline of 1.10%, ranking among the top declines in concept sectors, with notable declines from companies like Kexing Pharmaceutical, Yipinhong, and Ganli Pharmaceutical [1][2] - Among the 17 stocks that rose, Tainkang, *ST Sansheng, and Lanxiao Technology led with increases of 4.12%, 3.21%, and 2.31% respectively [1][2] - The weight loss drug sector saw a net outflow of 683 million yuan from main funds, with 33 stocks experiencing outflows, and 8 stocks seeing outflows exceeding 30 million yuan [2][4] Group 2 - Kexing Pharmaceutical had the highest net outflow of main funds at 116 million yuan, followed by Hanyu Pharmaceutical and Ganli Pharmaceutical with outflows of 112 million yuan and 109 million yuan respectively [2][4] - The stocks with the highest net inflow of main funds included Tainkang, Zhongsheng Pharmaceutical, and Changshan Pharmaceutical, with inflows of 34.43 million yuan, 23.74 million yuan, and 20.84 million yuan respectively [2][4] - The trading volume for Kexing Pharmaceutical was 7.99%, with a price drop of 14.19%, indicating significant trading activity despite the decline [3][4]